SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ligand (LGND) Breakout!
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
32384 154 0 LGND
Emcee:  Henry Niman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
31784GERN price move @ 4:00 P.M. Friday / Russell index re-balancing -- in case anyondavid nordic-6/25/2005
31783[Phase I trial of Bexarotene and Denileukin Diftitox in patients with relapsed otuck-6/24/2005
31782Lgnde could tahe a hit to the share price when the accounting is resolved. Revendavid nordic-6/23/2005
31781Right On the money. For the management team to disappear for 6 months plus is undavid nordic-6/20/2005
31780Agreed. Even if I do like his last name! JonRobohogs-6/20/2005
31779Nothing illegal has happened, according to Ligand, yet here we are 3 months latebiostruggle-6/20/2005
31778Large lay-offs at Purdue due to generic oxycontin. connpost.combiostruggle-6/18/2005
317773% per billion to the bottom line is not 3% to the top line. Lgnde's revenudavid nordic-6/16/2005
31776To double Ligands revenue the serm would have to reach 7 billion in sales. Remebiostruggle-6/16/2005
31775Serms are out already and PFE did additional studies. oporia has a better safetydavid nordic-6/16/2005
31774What are the odds it will be approved?SPSEIFERT-6/16/2005
31773Lgnde is getting ready for a 2X jump in share price. Operia is a multi-billion ddavid nordic-6/16/2005
31772This is the week for PFE/LGNDE's Oporia (Losofoxifene) NDA. SERM Class drug.david nordic-6/13/2005
31771American Diabetes Association's 65th Annual Scientific Sessions 6/10-6/14 david nordic-6/9/2005
31770RE:"If Robinson was smart he would rescind some the current avinza price inMonte High-6/7/2005
31769More "generic" extended release oxycontin coming to market. biz.yahoobiostruggle-6/7/2005
31768Analysts at Sanford C. Bernstein released sales forecasts for Byetta, a new diabdavid nordic-6/7/2005
31767Ligand's quarterly revenue is nearer to 45M than to Yahoos projected 60M. Widavid nordic-6/6/2005
31766Definition Thrombocytopenia is any disorder in which there are not enough pdavid nordic-6/6/2005
31765Ligand Earns $2 Million Milestone as GlaxoSmithKline Begins Phase I Development nigel bates-6/6/2005
31764RE: What does NPA monthly stand for? National Prescription Audit imshealth.usMonte High-5/25/2005
31763Avinza 4/04 At 3% IMS/NPA 40K At 12/31/04 4.3% 62K IMS/NPA and now 5/20/05 5.4%david nordic-5/25/2005
31762Wasn't referring to Targretin or Ontak; rather the 3% on the Pfizer drug.nigel bates-5/25/2005
31761Nigel, At under 3X revenue, Ligand would seem to be trading at something of a dHarold Engstrom-5/25/2005
31760Did I miss something from ASCO? Targretin without a new trial can not get a NDA david nordic-5/25/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News